dispatches from AAPS
Why Apple and Google hold the key to avoiding Pharmageddon
In the future pharma will be reliant on technology, says physician-scientist Daniel Kraft, who warns that companies which fail to innovate risk being left behind.
Archives for November 3, 2014
Quintiles shines again in Q3 with IHS leading the way
Quintiles reported almost 14% growth in revenue, which was largely due to increasing revenue from its Integrated Health Services (IHS), which saw almost 35% quarterly growth.
Bio-Rad settles bribery violations in Thailand, Russia and Vietnam for $55m
Bio-Rad Laboratories, a provider of research and clinical diagnostic products, has paid more than $55m to settle past violations of the Foreign Corrupt Practices Act (FCPA) that occurred from 2005 to 2010 related to Thailand, Vietnam, and Russia.
GSK, Sanofi see setbacks in flu vaccine production for US market
Two major influenza vaccine producers have run into manufacturing issues that have delayed and reduced the number of doses that will be provided for the US.
Novartis completes layoffs at Nebraska plant with 44 more departures
By dropping 44 more employees, Novartis has completed the final phase of the planned restructuring of its once-beleaguered Lincoln, Nebraska manufacturing facility.
Warburg Pincus buys 32% stake in Laurus citing ARVs and global opportunities
Warburg Pincus has bought a 32% stake in Indian API maker Laurus Labs Private Limited citing the ARV drug ingredients market and international opportunities as drivers.